Share Price, page-88

name a well drafted update to clearly explain the 4c and where strides fits in is essential to prove that we are making money.

the update should also confirm the progress with TGA on Artimist approval and marketing approval for Zolpimist, with Eddingpharm on CFDA application in mainland china, Zolpi Europe. Any updates on other products (not wishy washy crap) would be beneficial.

clear vision and disciplined/professional execution. Not panning for gold or snakeskin oil!

oh and if ABLM says were are getting a positive 4c this week then I expect to see one